Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 6 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 58 minutes agoThis is the first time final phase 3 data for a combined vaccine has been published by any firm. The...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine | Fox 11 Tri Cities Fox 41...
FOX 11/41 Yakima· 3 hours agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoRepresentatives from Moderna, Pfizer-BioNtech, and Novavax presented data about the protection...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA Today· 5 days agoCurrent vaccines built to fight XBB.1.5 also don’t provide as much protection against JN.1 and...
Whooping cough cases on the rise: What to know about symptoms, vaccines, more
USA Today· 5 days agoCases of whooping cough are popping up throughout the country and current case counts are nearly...
Will FLiRT COVID variants bring another summer surge? What to know about symptoms and potential for...
Fortune via Yahoo Finance· 5 days ago“Our currently available vaccines still do provide a notable measure of protection against these...
New biomarkers may enable personalized influenza vaccination schedule
Medical Xpress· 7 days agoNow, researchers have developed a way of classifying host immunity in individuals, which may lead to...
The Next COVID-19 Vaccine Is Coming. This Lineage of the Virus Is Its Likely Target.
US News & World Report· 5 days agoAnd most coronavirus infections in the U.S. currently come from descendants of JN.1, including KP.2 and KP.3, according to data from the Centers for Disease Control and Prevention ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 5 hours agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...